Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma

NCT02322775 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

211

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

BIOLOGICAL: Benralizumab
BIOLOGICAL: Placebo

Sponsor

AstraZeneca